Does SETMELANOTIDE Cause Off label use? 48 Reports in FDA Database
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Off label use have been filed in association with SETMELANOTIDE (Imcivree). This represents 26.4% of all adverse event reports for SETMELANOTIDE.
48
Reports of Off label use with SETMELANOTIDE
26.4%
of all SETMELANOTIDE reports
0
Deaths
21
Hospitalizations
How Dangerous Is Off label use From SETMELANOTIDE?
Of the 48 reports, 21 (43.8%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SETMELANOTIDE. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does SETMELANOTIDE Cause?
Nausea (53)
Skin hyperpigmentation (43)
Headache (27)
Skin discolouration (26)
Diarrhoea (24)
Vomiting (24)
Fatigue (23)
Decreased appetite (19)
Injection site pruritus (19)
Injection site erythema (17)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SETMELANOTIDE Alternatives Have Lower Off label use Risk?
SETMELANOTIDE vs SEVELAMER
SETMELANOTIDE vs SEVOFLURANE
SETMELANOTIDE vs SIBUTRAMINE
SETMELANOTIDE vs SILDENAFIL
SETMELANOTIDE vs SILODOSIN